Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
This project will experimentally establish a completely new method for accessing enantiopure materials starting from racemic substrates: stereoretentive-enantioconvergent catalysis. The ability to synthesize chiral molecules in enantiopure form is vitally important, most recognizably for the pharmaceutical industry. This is because the molecules of life are chiral (e.g., D-sugars and L-amino acids) and enantiomers often interact very differently with living organisms. Classically, asymmetric synthesis utilizing racemic substrates is limited to achieving a maximum yield of 50%. Enantioconvergent catalysis avoids this limitation with both enantiomers of the starting material being converted into a single enantioenriched product. This project will establish a conceptually new stereoretentive-dimerisation approach that results in both enantiomers of the starting material being incorporated into the product with no de-racemization required. This new concept will prove highly valuable for the synthesis of small enantiopure building blocks and complex molecules, which will be of high value in all areas of synthesis.
Louis Barriault
University of Edinburgh
Physics
Education
University of Ottawa
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.